Literature DB >> 3314688

Therapy of Pseudomonas aeruginosa eye infections.

H J Thiel1, K P Steuhl, G Döring.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3314688     DOI: 10.1159/000414337

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


× No keyword cloud information.
  6 in total

1.  Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice.

Authors:  K A Kernacki; D J Goebel; M S Poosch; L D Hazlett
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

2.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Bacterial keratitis in the critically ill.

Authors:  B Parkin; A Turner; E Moore; S Cook
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

4.  Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis.

Authors:  A Thakur; M Xue; F Stapleton; A R Lloyd; D Wakefield; M D P Willcox
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection.

Authors:  T S Zaidi; M J Preston; G B Pier
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.

Authors:  Thomas W Carion; Yuxin Wang; Ashten Stambersky; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  J Immunol       Date:  2022-04-25       Impact factor: 5.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.